• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.66% Nasdaq Up 0.88%

    Delcath Systems, Inc. (DCTH)

    -NasdaqCM
    0.30 Down 0.02(6.10%) May 2, 4:00PM EDT
    Prev Close:0.32
    Open:0.31
    Bid:0.27 x 2400
    Ask:0.55 x 2000
    1y Target Est:1.00
    Beta:1.05077
    Earnings Date:May 4 - May 9 (Est.)
    Day's Range:0.30 - 0.33
    52wk Range:0.25 - 1.92
    Volume:79,548
    Avg Vol (3m):130,903
    Market Cap:7.22M
    P/E (ttm):N/A
    EPS (ttm):-0.96
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for DCTH

    Comparison

    Symbol% ChgMkt Cap
    DCTHDown 6.10%7.22M
    LLYUp 1.62%81.59B
    PFEUp 0.28%203.09B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.35
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.12
    Quarterly EPS Est (Mar-16) :-0.19
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.02

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback